2nd Jul 2025 13:23
Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at EUR2.435 per share on Monday for a total of EUR52,353. Brings Patsi's shareholding in Faron to 53,265 shares, with 0.05% of company voting rights.
Current stock price: 213.10p, up 5.2% on Wednesday in London
12-month change: More than doubled from 93.50p on July 2, 2024
By Christopher Ward, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Faron Pharmaceuticals